Clinical trials

117

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Post-traumatic Estradiol Administration and Care Evaluation (PEACE)

This pilot randomized, double-blind, placebo-controlled trial evaluates the feasibility, acceptability, and tolerability of administering a single 6 mg oral dose of 17β-estradiol (E2) to individuals assigned female at birth who have experienced a sexual assault (SA) within the previous 120 hours. Thirty participants aged 18 to 45 years will be randomized 1:1 to receive either E2 or an identical-appearing placebo and followed for three months with blood collection and standardized assessments. The study will evaluate recruitment, enrollment, retention, biological responses, and preliminary clinical outcomes, including chronic musculoskeletal pain (CMSP) and posttraumatic stress disorder (PTSD), to inform the design of a future fully powered efficacy trial.

Participants needed: 30
Trial details
Phase: Phase 2Age: 18-45Biological sex: FemaleType: InterventionalSponsor: University of North Carolina, Chapel HillUpdated: Oct 9, 2026
Eligibility criteria

Aged 18 to 45 years [+4]

Pregnant or currently breastfeeding [+17]

Status: Recruiting

Sugary Drink Labeling Study

This study aims to examine the effects of added sugar warning labels on sugary drinks. Participants will be assigned to view either added sugar warning labels or control labels, applied on sugary drinks in an experimental store. Participants will shop for beverages in the store and take a computer survey at 4 visits spaced approximately 1 week apart.

Participants needed: 543
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: University of North Carolina, Chapel HillUpdated: Oct 8, 2026Locations: 1
Eligibility criteria

18 years and older [+2]

Living in the same household as someone else in the study

Status: Recruiting

Prospective Evaluation of an AI Diagnostic Ultrasound Tool for Fetal Weight Estimation

Purpose: The primary objective of this study is to assess the diagnostic accuracy of an AI-enabled ultrasound tool for estimating fetal weight Participants: 1,000 pregnant individuals Procedures (methods): This prospective diagnostic accuracy study will enroll 1,000 pregnant individuals within one week of anticipated delivery. At a single visit, each participant will undergo two ultrasound assessments: (1) standardized sweeps for AI analysis (performed by both specialist and nonspecialist users), (2) specialist-performed fetal biometry.

Participants needed: 1,000
Trial details
Age: 18+Biological sex: FemaleType: InterventionalSponsor: University of North Carolina, Chapel HillUpdated: Oct 6, 2026Locations: 6
Eligibility criteria

18 years of age or older [+4]

Maternal body mass index ≥ 40 kg/m² [+3]

Status: Recruiting

A Trial of Upadacitinib for Non-responsive Eosinophilic Esophagitis

The goal of this study is to find out if a medication called upadacitinib can help treat a condition called Eosinophilic Esophagitis (EoE). The main question it aims to answer are: \- Does upadacitinib in addition to topical corticosteroids help reduce EoE disease activity? Participants will: * Take upadacitinib or placebo every day for 12 weeks, followed by 12 weeks of upadacitinib * Fill out surveys and answer health questions * Visit the clinic every 4 weeks for checkups and tests

Participants needed: 52
Trial details
Phase: Phase 2Age: 18-65Biological sex: AllType: InterventionalSponsor: University of North Carolina, Chapel HillUpdated: Oct 6, 2026Locations: 2
Eligibility criteria

Age 18-65 years. [+7]

Use of systemic corticosteroids (such as prednisone or methylprednisolone) withi... [+20]

Status: Recruiting

Integrating New Skills Into Diabetes Education With CGM

This study is designed to test the preliminary efficacy of a three-stage continuous glucose monitor (CGM) integration program for older adults who are taking insulin. This study will learn if a three-stage CGM integration program ("intervention") that includes sessions focused on CGM technology skills, data skills, and lifestyle skills impacts CGM wear-time, glycemic metrics, and participant-reported outcomes, compared to two standard CGM training approaches ("comparators"). Following a screening visit and baseline data collection, participants will be randomized to either the intervention or one of the two comparator arms for 6 weeks. The intervention involves three educational sessions over 4 weeks. The first session will be in-person and subsequent sessions will be virtual. Participants in the intervention may receive 1-2 additional individualized training sessions to review CGM skills. The first comparator (Comparator 1) will receive a one-time clinic-based CGM training. The second comparator (Comparator 2) will be provided with a comprehensive informational pamphlet about CGM. All participants will complete outcomes data collection at 6 weeks. The study will also explore participant experiences through a series of semi-structured interviews with a subset of purposively selected participants and their care partners to identify opportunities for scaling the intervention to a broader population. An extension phase of the study will evaluate long-term CGM use and associated outcomes 3- and 6-months post-intervention. Lastly, we will run an additional small sub-study where consented care partners of participants will attend the intervention or comparator sessions alongside the study participant and provide care partner-specific data.

Participants needed: 144
Trial details
Age: 65+Biological sex: AllType: InterventionalSponsor: University of North Carolina, Chapel HillUpdated: Oct 5, 2026Locations: 1
Eligibility criteria

Adults 65 years and older at time of consent [+5]

Clinical diagnosis of dementia, assessed through chart review and self-report on... [+11]

Status: Recruiting

Leveraging Infant Visit PrEP INtegration & tasK Shifting to Improve Post-partum HIV Prevention in Malawi

The goal of the Leveraging Infant Visit PrEP INtegration \& tasK Shifting to Improve Postpartum HIV Prevention in Malawi (LINK) study is to evaluate both the effectiveness of a postpartum prevention package ("LINK model") among post-partum women and its implementation into existing clinical care models in Lilongwe, Malawi. The main question the study seeks to answer is: Do women at clinics implementing the LINK model have improved Pre-exposure Prophylaxis (PrEP) persistence compared to women at clinics receiving the standard of care? Researchers will compare the LINK model to standard of care by randomizing twelve sites to either the LINK model or the standard of care. Then researchers will review existing medical record and health surveillance data, and qualitative and quantitative data collected from intervention and control sites.

Participants needed: 5,000
Trial details
Age: 15-99Biological sex: AllType: InterventionalSponsor: University of North Carolina, Chapel HillUpdated: Sep 30, 2026Locations: 1
Eligibility criteria

Female enrolled in PrEP care at a study site [+2]

Female who has presented for PrEP visit at a participating clinical site at leas... [+6]

Status: Recruiting

Once Daily Intrapleural Enzyme Therapy in Complicated Parapneumonic Effusion or Empyema

The goal of this clinical trial is to find out if giving certain medications once a day works just as well as giving them twice a day to treat infections around the lungs (called pleural infections). These medications-tissue plasminogen activator (tPA) and deoxyribonuclease (DNase)-are placed through a chest tube into the space between the lung and the chest wall to help clear out the infection. The investigators are trying to learn: * Does using the medicine once a day work just as well as using it twice a day? * Are there any differences in outcomes between patients who get the medicine once a day versus twice a day? * Does more or less fluid remain in the chest (seen on a chest x-ray) depending on how often the medicine is given? Participants will: * Have an infection around their lung and will already be getting normal hospital care, including a chest tube to drain the infected fluid around their lung. * Be asked to give permission to join the study. * Be randomly chosen (like flipping a coin) to get the medications either once a day or twice a day through the chest tube.

Participants needed: 270
Trial details
Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: University of North Carolina, Chapel HillUpdated: Sep 29, 2026Locations: 11
Eligibility criteria

Written informed consent obtained from patient or patient's legally authorized r... [+4]

Known pregnancy or lactating females [+8]

Status: Not yet recruiting

Personalized Care for Prenatal Stress Reduction & Prevention of Preterm Birth (PTB) Disparities

The goal of this clinical trial is to learn if a personalized prenatal support program \[(Personalized Toolkit Building a Comprehensive Approach to Resource optimization and Empowerment in Pregnancy \& Beyond, (PTBCARE+)\] works to lower stress and lower the risk of early delivery in pregnant individuals at high-risk for delivering preterm. The main question\[s\] it aims to answer are: * Does the PTBCARE+ patient support program lower patient-reported stress levels during pregnancy? * Does the PTBCARE+ patient support program improve biologic measures of stress during pregnancy? * Does the PTBCARE+ patient support program result in a higher chance of delivering a healthy baby at or close to full term? Researchers will compare people who participate in the PTBCARE+ patient support program to those receive usual care to see if the PTBCARE+ patient support program lowers patient-reported stress, improves biologic measures of stress, and increases the chance of delivering a healthy baby at or close to full term. Participants will be randomly assigned to receive the PTBCARE+ patient support program or usual prenatal care. All participants will be asked to: * complete 2 study visits during pregnancy - including completing electronic surveys, providing a blood and urine sample, measuring the heart rate variability by a clip or the ear or finger, and body composition evaluation using a simple scale-like device. * complete one study visit postpartum that includes completing electronic surveys, and measuring heart rate variability. Blood and urine sample collection and body composition evaluation via InBody scale are optional at the postpartum visit. People who are randomly assigned to receive the PTBCARE+ support program will receive several resources to help them during pregnancy. These things include items such as: * a stress reduction toolkit; * access to an online website that can also be downloaded as a smart phone app; * the option to receive an electronic massage while in clinic, and more. * additional support gifts provided at routine clinical appointments People who are randomly assigned to receive usual prenatal care will not receive any additional support resources from the study during pregnancy.

Participants needed: 1,228
Trial details
Age: 18+Biological sex: FemaleType: InterventionalSponsor: University of North Carolina, Chapel HillUpdated: Sep 29, 2026Locations: 1
Eligibility criteria

Viable, singleton pregnancy, 8+0 to 19+6 weeks, dated by last menstrual period ±... [+18]

Participation in another intervention based clinical trial during pregnancy that... [+23]

Status: Recruiting

FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)

The goal of this clinical trial is to learn the best combination of family components that yields optimal weight loss among Black adults. The main question it aims to answer is: What combination of four family components in combination with a standard behavioral weight loss program yields optimal weight loss among Black adults? Researchers will compare different combinations of family skills components (communication content, cohesion content, number of sessions, and mode of delivery) to see the best weight loss. Participants will: * Participate in a 6-month behavioral weight loss intervention * Attend core weight loss in-person group sessions, and dyad based family sessions * Keep track of weight, dietary intake and physical activity

Participants needed: 256
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: University of North Carolina, Chapel HillUpdated: Sep 29, 2026Locations: 1
Eligibility criteria

self-identified as Black or African American (Index participant) [+7]

planning to move out of the area with the next 8-9 months [+11]

Status: Recruiting

Long-Term Study of COVID-19 Infection and Long COVID

This study will examine how common Long COVID is and how symptoms may persist over time in people who have previously had COVID-19. Researchers will collect information about participants' health and symptoms through questionnaires and may collect saliva and other non-invasive oral samples. The study will also examine biological factors in these samples that may be associated with persistent symptoms. The goal is to better understand why some people develop Long COVID and identify factors that may help predict who is more likely to experience persistent symptoms.

Participants needed: 500
Trial details
Age: 18-75Biological sex: AllType: ObservationalSponsor: University of North Carolina, Chapel HillUpdated: Sep 28, 2026Locations: 1
Eligibility criteria

Age 18 to 75 years. [+3]

Current severe periodontal disease with bleeding gums. [+5]

Status: Recruiting

E.N.D.E.A.V.O.R.: An Exemestane Needed Dose Efficacy and Verification as an Ovulation Induction Regimen Study

The goal of this clinical trial is to learn if study drug exemestane will increase chances of ovulation for patients with polyendocrine metabolic ovarian syndrome (PMOS, formerly called polycystic ovary syndrome (PCOS)). It will also learn about side effects of study drug exemestane in this study population. The main questions it aims to answer are: Does exemestane lead to ovulation for patients with polyendocrine metabolic ovarian syndrome (PMOS- formerly called PCOS)? Researchers will compare exemestane to a placebo (a look-alike substance that contains no drug) to see if exemestane helps PMOS patients ovulate. Participants will: Take exemestane or a placebo every day for 5-10 days Visit the clinic three times for ultrasounds, labs, and to answer questions about side effects. If they become pregnant during this study, they will tell us how their pregnancy went after the study via a registry online.

Participants needed: 40
Trial details
Phase: Phase 1Age: 18-40Biological sex: FemaleType: InterventionalSponsor: University of North Carolina, Chapel HillUpdated: Sep 23, 2026Locations: 1
Eligibility criteria

Premenopausal female (ages 18-40); [+6]

Under 18 or over 40 years of age; Individuals without the diagnosis of PCOS; [+11]

Status: Recruiting

Early Dental Risk Screening for Pediatric Sleep-Disordered Breathing

This is a prospective, cross-sectional observational study designed to evaluate the Pediatric Sleep Questionnaire (PSQ) as a screening tool for sleep-disordered breathing (SDB) risk in a pediatric dental setting. Children aged 8-13 years will be classified as low- or high-risk for SDB based on PSQ scores and compared using physiologic sleep parameters obtained from a wearable, FDA-cleared home sleep monitoring device, alongside psychosocial assessments and craniofacial measurements derived from lateral cephalometric radiographs. Findings will inform the feasibility and accuracy of incorporating validated SDB screening into routine pediatric dental care.

Participants needed: 60
Trial details
Age: 8-13Biological sex: AllType: ObservationalSponsor: University of North Carolina, Chapel HillUpdated: Sep 23, 2026Locations: 1
Eligibility criteria

Ages 8-13 years old [+4]

Diagnosis of a craniofacial syndrome or condition known to significantly alter c... [+4]

Status: Recruiting

Effects of "Alliance180 Program" on Well-Being

The goal of this clinical trial is to evaluate the effects of the Alliance180 Program on physical and psychological well-being on adults who are/were US Veterans, First Responders and/or Front Line Healthcare Workers. The study aims are: * Aim #1: to evaluate the effect of the Alliance180 Program on physical and psychological well-being in adults who are/were US Veterans, First Responders and/or Front Line Healthcare Workers; * Aim #2: to evaluate the relationship between between feelings of safety and well-being, autonomic functioning, and mental health indices (depression, anxiety, trauma response) before and after the intervention. Participants will be asked to complete self-report measures of feelings of safety and well-being, autonomic functioning, and mental health indices (depression, anxiety, trauma response) before participating in the Alliance180 Program (i.e., baseline research session) and 1 week, 1 month, 3 months and 6 months after completing the Alliance180 Program. Demographic information will be documented during the baseline research session.

Participants needed: 50
Trial details
Age: 18-99Biological sex: AllType: InterventionalSponsor: University of North Carolina, Chapel HillUpdated: Sep 21, 2026Locations: 2
Eligibility criteria

18 years or older [+1]

Status: Recruiting

Evaluation of a Differentiated Point-of-care Active Case Finding & Management Model to Eliminate Mother-to-Child Transmission of HIV in Malawi

Purpose: To conduct a hybrid effectiveness-implementation stepped-wedge trial to: 1. Estimate the effect of the PAC-Man model, compared to SOC, on the proportion of infants who receive timely EID testing. 2. Estimate the effect of the PAC-Man model, compared to SOC, on the proportion of pregnant and breastfeeding women living with HIV who receive guideline-adherent viral load testing. 3. Compare implementation outcomes between the PAC-Man model and SOC. Participants: The total study sample size is 2,426, including 2,304 mother-infant pair (MIP) survey participants, 48 high-risk pregnant/breastfeeding women living with HIV for in-depth interviews (from high-risk MIPs who participated in a survey); 10 PMTCT policy makers and Ministry of Health (MOH)/ President's Emergency Plan for AIDS Relief (PEPFAR) implementing partner senior managers for key informant interviews; and about 48-64 professional and lay health providers for focus group discussions and implementation actor surveys. To rigorously evaluate the PAC-Man model, investigators will use a hybrid (type 3) effectiveness-implementation incomplete stepped-wedge trial design. The hybrid incomplete stepped-wedge design is a rigorous quasi-experimental design that allows for incremental "rollout" of the PAC-Man model and serial measurement of both health outcomes (for infants and mothers in Objectives 1 and 2, respectively), as well as implementation outcomes (Objective 3). The incomplete stepped-wedge design is more efficient than a complete design, minimizes costs, and reduces participant burden, without sacrificing statistical precision. Using this design, sequential crossover from control (i.e., the SOC) to intervention (i.e., SOC plus the PAC-Man model) takes place at each 'step' using cluster randomization until all clusters (defined as a group of "sites," or health facilities plus the surrounding communities in its catchment area) receive the intervention. The 12 sites included in our study will be divided into 4 clusters of 3 sites each.

Participants needed: 2,426
Trial details
Age: 16+Biological sex: AllType: InterventionalSponsor: University of North Carolina, Chapel HillUpdated: Sep 18, 2026Locations: 3
Eligibility criteria

Enrolled in the national EMTCT program at a study site in the 12 months precedin...

None. [+22]

Status: Recruiting

Adolescent Mental Health Parenting Program for Child-Adult Relationship Enhancement

The purpose of this research study is to learn if a parenting program called Adolescent Mental Health Parenting Program for Child Adult Relationship Enhancement (AMP-CARE) can help parents have more confidence in parenting their teen and improve their knowledge about normal teen development and teen mental health. The main questions it aims to answer are: * Does the AMP-CARE parenting program improve confidence in teen parenting and positive parenting? * Does the AMP-CARE parenting program improve parent knowledge about mental health? Researchers will compare participants who complete the parenting program to those who do not. Participants will: * Complete 2 surveys, one at the start of the study and one 6 -12 weeks later * Half of the participants will be randomly picked to attend the 6 virtual AMP-CARE sessions right away. * The other half will have the opportunity to attend AMP-CARE after they complete the second survey.

Participants needed: 60
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: University of North Carolina, Chapel HillUpdated: Sep 18, 2026Locations: 2
Eligibility criteria

Parent or guardian of teen age 11-14 years [+2]

Parents of children with severe mental illness (indicated by psychiatric hospita... [+2]

Status: Not yet recruiting

Pilot HIV Self-Testing And Self-collected STI Testing Strategy for Sex Worker Empowerment Study

The goal of this clinical trial is to find out if sex work managers (also called "queen mothers") can help female sex workers (FSW) get tested for HIV and other sexually transmitted infections (STIs) by giving out and collecting test kits at the places where FSW meet and work, also known as venues. This study will also find out if this approach helps link FSW to HIV and STI treatment and prevention services. The main questions it aims to answer are: * Can this approach increase HIV diagnosis and connection to HIV treatment and prevention services? * Can this approach increase STI diagnosis and connection to STI treatment services? * Is this approach acceptable, appropriate, and feasible, and what are the costs associated with the approach? Researchers will compare a venue-based, peer-supported strategy for HIV self-testing and self-collected STI testing among FSW to the current standard of care to see if the new approach helps to increase HIV and STI identification and linkage to HIV and STI treatment and prevention services. FSW participants will: * Complete questionnaires when they join the study and again about three months later. * Complete HIV self-testing and self-collected STI testing when they join the study and again about three months later (at intervention sites), with the help of queen mothers. * Agree to have their medical records reviewed. Queen mother participants will: * Complete questionnaires when they join the study and again about three months later. * Help FSW participant complete HIV self-testing and self-collected STI testing when they join the study and again three months later (at intervention sites). Additionally, some FSW participants will complete a one-time interview so that the investigators can learn more about their experiences with and views on HIV and STI services. The investigators will also be holding focus group discussions with queen mothers, clinicians, and others involved in study activities to understand their experiences with providing services through the study strategy.

Participants needed: 232
Trial details
Age: 18+Biological sex: FemaleType: InterventionalSponsor: University of North Carolina, Chapel HillUpdated: Sep 18, 2026Locations: 1
Eligibility criteria

Born biologically female [+7]

Under the age of 18 years [+12]

Status: Not yet recruiting

Light Bulb Stimuli to Reduce Chronic Pain

This pilot randomized, double-blind, crossover clinical trial will evaluate the feasibility and preliminary efficacy of chromatic (colored) light exposure for reducing pain severity and pain sensitivity in adults with fibromyalgia or chronic widespread pain and fatigue. Participants will complete daily symptom surveys throughout the study and undergo patient-reported outcome assessments and quantitative sensory testing at multiple timepoints. Participants will be randomized to receive either S-cone stimulating chromatic light or equal-energy white light for 2 hours daily over a 7-day treatment period. Following a 1-week washout, participants will cross over to the alternate condition. Outcomes will examine feasibility, changes in pain severity, pain interference, and measures of pain sensitivity. Total study duration is approximately 35 days.

Participants needed: 40
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: University of North Carolina, Chapel HillUpdated: Sep 17, 2026Locations: 1
Eligibility criteria

Adults ≥ 18 years of age. [+9]

Vision disorders or conditions resulting in severe vision impairment or blindnes... [+8]

Status: Recruiting

Comparing a Workplace Resilience and a Physical Activity Intervention on Early Childhood Educators Well-being

The goal of this 15-month cluster clinical trial is to compare a resilience and stress management program to a physical activity program for early childhood education (ECE) staff on change in well-being. It will also look to see if changes in well-being continue over time. The study sample will include 80 child care centers. Including 80 ECE center directors and approximately 560 ECE center staff. Some ECE centers will receive only the remotely delivered Resilience program. This program works with ECE staff and helps them recognize and strengthen their resilience assets and resources. Other ECE centers will receive only the remotely delivered Physical Activity program that will focus on staff physical activity habits and strength training. There will be 3 months of active program participation and 12 months of a maintenance period where participants will only have access to program materials.

Participants needed: 640
Trial details
Age: 18-99Biological sex: AllType: InterventionalSponsor: University of North Carolina, Chapel HillUpdated: Sep 8, 2026Locations: 1
Eligibility criteria

Licensed with no plans to close in the next 2 years [+6]

None

Status: Recruiting

Daily Upgrade Trial

This study evaluates the acute and chronic effects of an essential amino acid supplement (Daily Upgrade EAA+) on metabolomics, amino acid kinetics, metabolic rate, body composition in active adult women. The study consists of an acute randomized double-blind crossover phase comparing EAA+, whey protein isolate, and placebo before high-intensity interval training (HIIT), and a chronic randomized double-blind parallel-arm phase evaluating 3 weeks of EAA+ or placebo supplementation combined with twice-weekly HIIT.

Participants needed: 44
Trial details
Age: 25-45Biological sex: FemaleType: InterventionalSponsor: University of North Carolina, Chapel HillUpdated: Sep 3, 2026Locations: 1
Eligibility criteria

Participant is an adult between the ages of 25-45 years [+7]

Participant has been diagnosed with chronic heart disease, arrhythmias, thyroid... [+6]

Status: Recruiting

Teachers Leading the Front Lines - North Carolina (Tealeaf-NC)

Purpose: The purpose of this research is to pilot test a novel, alternative, potentially sustainable system of teacher-delivered, task-shifted child mental health care. Participants: \~300 estimated Procedures: This is a RE-AIM (Reach, Effectiveness, Adoption, Implementation, Maintenance) guided, mixed methods, clustered evaluation of Tealeaf-NC's Reach, Adoption \& Implementation (Primary Outcomes, implementation-based), as well as evaluating for preliminary indicators of Effectiveness \& Maintenance (Secondary Outcomes, clinically-based).

Participants needed: 312
Trial details
Age: 5-99Biological sex: AllType: InterventionalSponsor: University of North Carolina, Chapel HillUpdated: Sep 3, 2026Locations: 1
Eligibility criteria

Have been trained in either Tealeaf or RE-SEED in Summer 2024 or 2025 after bein... [+19]

Exclusion criteria will be set as each participant does not meet the inclusion c...

Status: Recruiting

3-D Tractography FUS Ablation for Essential Tremor

The investigators propose to advance Vim-FUSA (Ventral Intermediate Nucleus - Focused Ultrasound Ablation) with the support of 3-D tractography, a neuroimaging technique to visually represent nerve tracts within the brain. The investigators hypothesize that 3-D tractography Vim-FUSA will improve the Vim ablation compared to standard Vim-FUSA and prove safe and feasible in the clinical setting. The investigators also hypothesize that intraoperative magnetic resonance (i-MR) monitoring will differentiate ablated tissue from immediate perilesional edema and accurately predict the Vim-FUSA clinical outcomes.

Participants needed: 24
Trial details
Age: 22+Biological sex: AllType: InterventionalSponsor: University of North Carolina, Chapel HillUpdated: Sep 8, 2026Locations: 1
Eligibility criteria

Diagnosis of moderate to severe ET agreed upon by at least two movement disorder... [+4]

Uncontrolled hypertension [+13]

Status: Not yet recruiting

Single Session Personalized Aperiodic Transcranial Alternating Current Stimulation (PandA-tACS) for Antenatal Depression

The purpose of this pilot trial is to primarily assess safety, feasibility, and tolerability of PandA-tACS in antenatal depression and determine whether a single PandA-tACS session produces greater left dlPFC aperiodic slope flattening (reduction) from pre- to post-stimulation than IAF-tACS and sham.

Participants needed: 60
Trial details
Age: 18-45Biological sex: FemaleType: InterventionalSponsor: University of North Carolina, Chapel HillUpdated: Sep 2, 2026
Eligibility criteria

Aged 18 - 45 [+5]

DSM-5 diagnosis of severe alcohol use disorder (AUD) within the last 12 months,... [+47]

Status: Recruiting

Caring Connections Youth Suicide Detection and Intervention Study

The goal of this pilot randomized control trial (RCT) is to test the feasibility of Caring Connections, a Culturally Adapted Linking Individuals Needing Care (CA-LINC) suicide prevention care coordination intervention for high-risk suicidal youth. This consumer-, community-, and theory-driven care coordination intervention is designed to reduce suicide ideation and behavior (SIB) by improving service engagement. Connections is a 90-day intervention that integrates engagement and follow-up strategies to assess/monitor suicide risk, facilitate service use referrals/linkages, develop/refine safety plans, and create villages of care. The intervention incorporates cultural promotive factors, empowerment, and motivational strategies aimed at supporting youth, enhancing strengths, promoting hope, improving family relationships, and reinforcing caring messages. Primary research questions include: Is Caring Connections feasible to use for suicidal high-risk youth? Does Caring Connections have the potential to reduce suicide ideation and behaviors among high-risk suicidal youth? For the pilot RCT, 80 youth participants ages 13-19 who meet the inclusion criteria will be randomly assigned to one of two conditions: Caring Connections (n=40) or Treatment as Usual (n=40). Additionally, investigators will enroll 80 caregivers of youth meeting inclusion criteria and 20 Mental Healthcare, Healthcare Providers, Community Stakeholders, and/or Care Coordinators with experience working with suicidal youth. Researchers will compare those receiving Caring Connections with treatment as usual to see if suicidal ideation and behaviors, and engagement.

Participants needed: 180
Trial details
Age: 13+Biological sex: AllType: InterventionalSponsor: University of North Carolina, Chapel HillUpdated: Sep 4, 2026Locations: 1
Eligibility criteria

13 - 19 years old [+20]

Youth at imminent suicide risk (reported verbally and/or indicated on C-SSRS) [+4]

Status: Recruiting

Evaluation of the Melanin-Adjusted Blood Oxygen Sensor (MABOS) in ICU Settings

Purpose: Investigate the accuracy of the investigators' novel pulse oximeter across a broad range of skin-pigmentations and oxygen saturations. Participants: Up to 120 adult participants admitted to Medical Intensive Care, or Cardiovascular Thoracic Critical Care, Units. Procedures (methods): Participants will have their skin tone measured on each finger using a spectrophotometer. During the study, participants will wear one of the investigators' custom devices - MABOS - on one finger of each hand. Additionally, they will wear a variant of the investigators' device on an additional finger and outer side of the associated wrist. The study team will continuously acquire data from all devices until either 4 Arterial Blood Gas tests have been collected, or 24 hours have elapsed.

Participants needed: 120
Trial details
Age: 18-85Biological sex: AllType: InterventionalSponsor: University of North Carolina, Chapel HillUpdated: Sep 2, 2026Locations: 1
Eligibility criteria

Age ranges from 18 to 85 years. [+3]

History of active (clinically significant) skin disorders that make skin vulnera... [+10]

Status: Not yet recruiting

Mediterranean Dietary Intervention for HS

The goal of this clinical trial is to learn whether a 16-week Mediterranean-style dietary counseling program, called the Med-South Lifestyle Program (MSLP), is practical and acceptable for adults with hidradenitis suppurativa (HS). The study will also look at whether participants' Mediterranean diet adherence changes during the program. The main questions it aims to answer are: * Do participants find the program feasible and practical to follow? * Does adherence to a Mediterranean-style diet change from the beginning to the end of the 16-week program? * Do participants find the program acceptable? All participants will receive the same program; there is no comparison group. Participants will: * Take part in individual nutrition counseling and shorter support calls, mostly by video or telephone * Complete a cooking education session and receive written nutrition materials * Receive Mediterranean-style food support, including pantry staples and prepared meals * Attend two in-person study visits, at the beginning and end of the 16-week program * Complete questionnaires and study assessments and provide biological samples Because this is a pilot study, the information collected will primarily be used to improve the program and help plan a larger future clinical trial.

Participants needed: 30
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: University of North Carolina, Chapel HillUpdated: Sep 2, 2026Locations: 1
Eligibility criteria

Age 18 years or older [+5]

Systemic antibiotic use (oral, intramuscular, or intravenous) within 28 days bef... [+4]